Synthesis of Tetrahydrohonokiol Derivates and Their Evaluation for Cytotoxic Activity against CCRF-CEM Leukemia, U251 Glioblastoma and HCT-116 Colon Cancer Cells
- Supplementary File 1:
Supplementary Materials (PDF, 866 KiB)
Bernaskova, M.; Kretschmer, N.; Schuehly, W.; Huefner, A.; Weis, R.; Bauer, R. Synthesis of Tetrahydrohonokiol Derivates and Their Evaluation for Cytotoxic Activity against CCRF-CEM Leukemia, U251 Glioblastoma and HCT-116 Colon Cancer Cells. Molecules 2014, 19, 1223-1237. https://doi.org/10.3390/molecules19011223
Bernaskova M, Kretschmer N, Schuehly W, Huefner A, Weis R, Bauer R. Synthesis of Tetrahydrohonokiol Derivates and Their Evaluation for Cytotoxic Activity against CCRF-CEM Leukemia, U251 Glioblastoma and HCT-116 Colon Cancer Cells. Molecules. 2014; 19(1):1223-1237. https://doi.org/10.3390/molecules19011223
Chicago/Turabian StyleBernaskova, Marketa, Nadine Kretschmer, Wolfgang Schuehly, Antje Huefner, Robert Weis, and Rudolf Bauer. 2014. "Synthesis of Tetrahydrohonokiol Derivates and Their Evaluation for Cytotoxic Activity against CCRF-CEM Leukemia, U251 Glioblastoma and HCT-116 Colon Cancer Cells" Molecules 19, no. 1: 1223-1237. https://doi.org/10.3390/molecules19011223